Nobel laureate: Ethics debate unstilled by stemcell success

Nov 12, 2012 by Olivier Thibault
Japanese Kyoto University professor Shinya Yamanaka, who won the 2012 Nobel Prize in Medicine with John B. Gurdon of Britain, answers to journalists' questions in Paris. Yamanaka cautioned that stem cells could still spur sharp debate, despite his achievement in creating cells that are not derived from embryos.

Newly-crowned Nobel laureate Shinya Yamanaka on Monday cautioned that stem cells could still spur sharp debate, despite his achievement in creating cells that are not derived from embryos.

The Japanese scientist was interviewed on a trip to Paris after co-winning the 2012 Nobel Prize for Medicine last month alongside Britain's John Gurdon.

Yamanaka was lauded for "reprogramming" so that they return to a versatile primitive state, called stem cells.

Researchers hope that stem cells may one day provide lab-grown tissue to replenish organs damaged by accident or disease.

Only the very first steps have been taken along this road, but the mission has been boosted by Yamanaka's work, for it implies that culled from embryos—until now the most potent but also a highly controversial source—may no longer be needed.

But Yamanaka warned that his induced (iPS) are unlikely to escape a storm touching on the creation of life.

"Now we can avoid the use of , so it's good. However, we are facing new ," he told AFP.

The question, he said, lies with the creation of so-called —cells that give rise to sperm or eggs.

"Can we make sperm from blood and can we fertilise these oocytes (eggs)?" he asked. "We really need discussion in society about how much we can do about this new technology."

Yamanaka said scientists in Kobe had already applied to the Japanese authorities for permission to carry out the world's first iPS trial on humans, using cells on patients suffering from .

And, he said, Japan was pushing ahead with a stem cell bank, which was approved in July.

"In theory, we can make iPS cells from each patient. But it would be very expensive and take six months to prepare the cells from each patient. So in reality, we cannot do that," he said.

A stem cell bank would be a good alternative, said Yamanaka.

The idea is to choose donors whose is least likely to trigger rejection by a patient's immune system.

"We may be able to cover many patients by having only a handful of iPS stock, that's our plan," he said. "By our estimations, we identified 140 such specific donors, (and with these) we could cover up to 90 percent of the whole population."

Some scientists have been cautious about iPS technology, fearing that reprogramming errors as an adult cell is rewound to its infant state, using a batch of introduced genes, could cause tumours.

Yamanaka, 50, carried out his groundbreaking work in 2007, but was quick to pay tribute to Gurdon, who laid the conceptual foundations in 1962.

In 2007, "We thought maybe we will win the Nobel prize in the future if it goes" to clinical trials, he said.

"So we did not expect (it) at this time because it was too early. But we were awarded because of Sir John Gurdon and his discovery 50 years ago... Because of him I was very lucky to be awarded."

Explore further: Research sheds light on what causes cells to divide

add to favorites email to friend print save as pdf

Related Stories

Japan Nobel laureate gets washing machine as gift

Oct 19, 2012

Japan's Shinya Yamanaka may have won $1.2 million along with British researcher John Gurdon when the two were awarded the Nobel Prize for medicine earlier this month, but now he is also getting a new washing machine.

The future of stem cell research

Dec 08, 2010

Perhaps no single scientist has had a greater impact on stem cell research than Dr. Shinya Yamanaka. While most of his colleagues were looking for ways to grow human embryonic stem cells into replacement tissues for treating ...

Critical process in stem cell development identified

Jul 05, 2012

Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell--called an iPS cell--that is derived from adult skin cells. This discovery offers newfound ...

Recommended for you

Research sheds light on what causes cells to divide

Dec 24, 2014

When a rapidly-growing cell divides into two smaller cells, what triggers the split? Is it the size the growing cell eventually reaches? Or is the real trigger the time period over which the cell keeps growing ...

Locking mechanism found for 'scissors' that cut DNA

Dec 24, 2014

Researchers at Johns Hopkins have discovered what keeps an enzyme from becoming overzealous in its clipping of DNA. Since controlled clipping is required for the production of specialized immune system proteins, ...

Scrapie could breach the species barrier

Dec 24, 2014

INRA scientists have shown for the first time that the pathogens responsible for scrapie in small ruminants (prions) have the potential to convert the human prion protein from a healthy state to a pathological ...

Extracting bioactive compounds from marine microalgae

Dec 24, 2014

Microalgae can produce high value health compounds like omega-3s , traditionally sourced from fish. With declining fish stocks, an alternative source is imperative. Published in the Pertanika Journal of Tr ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.